Lotus‘ operating entity, Beijing Liang Fang Pharmaceutical, purchased the land-use rights for the property in 2008. Lotus had originally intended to build a pharmaceutical manufacturing and storage facility on a portion of the property.
In March 2010, Lotus began construction on a 250,000sqft facility in Beijing after receiving permission from the Beijing Chaoyang District Planning Bureau.
The new building will house the company’s R&D center, manufacturing operations, storage facilities, sales and administrative offices. The building will become Lotus’ new corporate headquarters following its completion. Management expects to move into the building by June 2011.
Lotus chairman and CEO Zhongyi Liu said they have decided not to move forward with the construction of their planned facility in Inner Mongolia in order to focus their efforts and resources on expanding core business in Beijing.
"We believe that selling or transferring this property will be a more effective use of our capital," Liu said.